pyrrolidine dithiocarbamate has been researched along with Lupus Erythematosus, Systemic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cao, HY; Li, D; Li, HB; Lu, HX; Sun, J; Wang, YP | 1 |
Ding, SS; Feng, YJ; Wang, XH; Ye, DQ; Zhai, JX; Zhang, ZX; Zou, LW | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Lupus Erythematosus, Systemic
Article | Year |
---|---|
The protection of NF-κB inhibition on kidney injury of systemic lupus erythematosus mice may be correlated with lncRNA TUG1.
Topics: Animals; Complement C3; Female; Immunoglobulin G; Inflammation Mediators; Kidney; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; NF-kappa B; Pyrrolidines; RNA, Long Noncoding; Thiocarbamates | 2020 |
PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
Topics: Animals; Antibodies, Antinuclear; Antioxidants; Chemokine CCL2; Female; Gene Expression; Gene Expression Regulation; Glomerulonephritis, Membranoproliferative; Kidney; Lipopolysaccharides; Lupus Erythematosus, Systemic; MAP Kinase Signaling System; Mice; Mice, Inbred MRL lpr; Mitogen-Activated Protein Kinases; Phosphorylation; Proteinuria; Pyrrolidines; Renal Insufficiency; Thiocarbamates; Transcription Factor RelA | 2012 |